← Back to catalogue

Trinity Biotech

FDA UDI

Class II (US FDA UDI)

by Clark Laboratories, Inc.

Identity

Trade Name
Trinity Biotech FDA UDI
Generic Name
Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control FDA UDI
Device Name
G6PDH Control, Deficient FDA UDI
Model / Reference
G5888 FDA UDI
Description
G6PDH Control, Deficient FDA UDI

Identifiers

Catalog Number
G5888 FDA UDI
Primary DI / UDI-DI
05391516743143 FDA UDI
510(k) Number
K802568 FDA UDI
FDA Product Code
KHG FDA UDI
GMDN Term
Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7500 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control

Trinity Biotech by Clark Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 9f644b76-5478-4b5f-bff6-06c398fd56ed 38 fields · synced Jun 8, 2026